Ben Dickstein

Ben Dickstein has a diverse work experience in the biotechnology and engineering fields. Ben is currently working at Lyndra Therapeutics as a Scientist I, where they joined in November 2022. Prior to this, they held the role of Sr. Associate Scientist, Formulations at Lyndra Therapeutics from July 2021 to December 2022.

Before joining Lyndra Therapeutics, Ben worked as a Graduate Researcher (Putnam Group) at the Meinig School of Biomedical Engineering at Cornell University from January 2020 to July 2021. Ben also worked as a Formulations Co-Op at Lyndra Therapeutics from September 2020 to January 2021.

Ben gained additional experience as a Graduate Software Engineer Intern at MITRE in July and August 2020. Ben was an Undergraduate Researcher (Wang Lab: Biofoundry) at Cornell University from September 2018 to December 2019.

Furthermore, Ben had internships at Biogen as an Antisense Oligonucleotide Intern from May 2019 to August 2019, at Moderna Therapeutics as a Formulations Intern from June 2018 to August 2018, at Tufts University as a Biomolecular Engineering Research Intern (Xu Lab) in June and August 2017, and at Allurion Technologies as an Engineering Intern in July and August 2015.

Overall, Ben Dickstein has gained valuable experience in various research and engineering positions, particularly in the fields of drug formulations and biomedical engineering.

Ben Dickstein received their Bachelor of Science degree in Biomedical Engineering from Cornell University in 2020. Ben then went on to pursue a Master of Engineering degree in Biomedical Engineering at the same institution, which they completed in 2021. Prior to their undergraduate studies at Cornell, Ben attended Wayland High School from 2012 to 2016. No specific degree or field of study was mentioned for their high school education.